ELV · 10-Q · 2026Q2 · Full report

Net Losses on Financial Instruments

Elevance Health, Inc. · 2026-07-15 · Importance 45 · Surprise 64

Net losses on financial instruments decreased to a net loss of $56 million for the three months ended June 30, 2026 from $131 million in the prior-year quarter, a 57.3% improvement. The MD&A attributes the decrease to lower impairment on other invested assets and lower realized losses on sales of financial instruments. For the six months, net losses on financial instruments improved by 77.5% year-over-year, reducing downside volatility in total revenues.

Key facts

• Net losses on financial instruments for the three months ended June 30, 2026 were $(56) compared to $(131) for the three months ended June 30, 2025, a decrease in net losses (57.3%). source